Diabetes mellitus and renal failure: Prevention and management
- PMID: 26941817
- PMCID: PMC4755100
- DOI: 10.4103/1735-1995.172845
Diabetes mellitus and renal failure: Prevention and management
Abstract
Nowadays, diabetes mellitus (DM) and hypertension are considered as the most common causes of end-stage renal disease (ESRD). In this paper, other than presenting the role of DM in ESRD, glucose metabolism and the management of hyperglycemia in these patients are reviewed. Although in several large studies there was no significant relationship found between tight glycemic control and the survival of ESRD patients, it is recommended that glycemic control be considered as the main therapeutic goal in the treatment of these patients to prevent damage to other organs. Glycemic control is perfect when fasting blood sugar is less than 140 mg/dL, 1-h postprandial blood glucose is less than 200 mg/dL, and glycosylated hemoglobin (HbA1c) is 6-7 in patients with type 1 diabetes and 7-8 in patients with type 2 diabetes. Administration of metformin should be avoided in chronic renal failure (CRF) because of lactic acidosis, the potentially fatal complication of metformin, but glipizide and repaglinide seem to be good choices.
Keywords: Chronic kidney disease; World Kidney Day; diabetes mellitus (DM).
Similar articles
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.Am J Cardiovasc Drugs. 2007;7(5):319-35. doi: 10.2165/00129784-200707050-00002. Am J Cardiovasc Drugs. 2007. PMID: 17953471 Review.
-
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.Clin Ther. 2003 Mar;25(3):890-903. doi: 10.1016/s0149-2918(03)80112-1. Clin Ther. 2003. PMID: 12852706 Clinical Trial.
-
The Phantom of Metformin-Induced Lactic Acidosis in End-Stage Renal Disease Patients: Time to Reconsider with Peritoneal Dialysis Treatment.Perit Dial Int. 2017 1-2;37(1):56-62. doi: 10.3747/pdi.2015.00309. Epub 2016 Sep 28. Perit Dial Int. 2017. PMID: 27680758
-
Diagnosis and management of diabetes and the relationship of dglucose to kidney function.Curr Diabetes Rev. 2015;11(2):116-21. doi: 10.2174/1573399811666150302111453. Curr Diabetes Rev. 2015. PMID: 25732030 Free PMC article. Review.
Cited by
-
Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature.Front Public Health. 2016 Aug 31;4:189. doi: 10.3389/fpubh.2016.00189. eCollection 2016. Front Public Health. 2016. PMID: 27630984 Free PMC article. Review.
-
Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.PLoS One. 2016 Nov 10;11(11):e0166342. doi: 10.1371/journal.pone.0166342. eCollection 2016. PLoS One. 2016. PMID: 27832180 Free PMC article.
-
Associations of TCF7L2 gene polymorphisms with the risk of diabetic nephropathy: A case-control study.Medicine (Baltimore). 2018 Oct;97(40):e8388. doi: 10.1097/MD.0000000000008388. Medicine (Baltimore). 2018. PMID: 30290587 Free PMC article.
-
Modulation of Calcium Homeostasis May Be Associated with Susceptibility to Renal Cell Carcinoma in Diabetic Nephropathy Rats.Cancer Manag Res. 2020 Oct 7;12:9679-9689. doi: 10.2147/CMAR.S268402. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116827 Free PMC article.
-
Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase-4 inhibitors: Real world evidence from the Nordic EMPRISE study.Diabetes Obes Metab. 2023 Jan;25(1):261-271. doi: 10.1111/dom.14870. Epub 2022 Oct 10. Diabetes Obes Metab. 2023. PMID: 36097728 Free PMC article.
References
-
- Abboud H, Henrich WL. Clinical practice. Stage IV chronic kidney disease. N Engl J Med. 2010;362:56–65. - PubMed
-
- Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82. - PubMed
-
- Ardalan MR, Nasri H. Lessons from our paleolithic primogenitors; a short look to the world diabetes day 2014 with the theme of “healthy living and diabetes”. J Parathyr Dis. 2014;2:57–8.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources